New radiation method aims to improve sarcoma surgery outcomes
NCT ID NCT04219202
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new, faster radiation treatment using protons or carbon ions before surgery for a rare type of cancer called retroperitoneal soft tissue sarcoma. The goal is to see if this approach is safe and practical. About 64 adults whose tumors can be surgically removed will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETROPERITONEAL SOFT-TISSUE SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Heidelberg, Radiation Oncology
RECRUITINGHeidelberg, 69120, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Tumor-Injected drug combo outlast standard care in advanced sarcoma?
- Cancer-Killing virus injected directly into tumors shows promise in Mid-Stage trial
- New drug combo shows promise for rare sarcoma
- New chemo combo shows promise for rare sarcoma
- New drug cocktail shows promise for rare sarcomas
- New study tracks how cancer surgery affects Kids' walking